MondayOct 09, 2023 12:40 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Emergency Communication Systems Deployed for Four Existing Customers

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced new purchase orders. The orders are from four existing customers – two cities and two universities – seeking to grow and improve their emergency communications systems. The announcement reads, “Advocates, individuals and government officials at all levels must do everything they can to ensure that schools are safe places for students, teachers and other employees. A university in Delaware is expanding their 15-phone emergency communication system with 3 K1 Blue Light Emergency Phones. A Southern California university added Knightscope’s K1B Maintenance Plan…

Continue Reading

MondayOct 09, 2023 11:43 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints Marianne McInerney as Chief Strategy Officer

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the appointment of Marianne McInerney as chief strategy officer. According to the announcement, McInerney will focus on growth opportunities and drive strategic initiatives for Mullen’s commercial, consumer vehicles and governmental affairs. McInerney has nearly two decades of experience in the automotive and transportation industry, during which she has advised multiple original equipment manufacturers, governmental entities and tier one suppliers and held vital positions at next-generation vehicle OEMs, the U.S. Department of Transportation, and the American International Automobile Dealers Association. “Marianne is a key addition to our team and…

Continue Reading

FridayOct 06, 2023 11:28 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Continues Growth, Momentum with New Emergency Communications Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is seeing consistent success and growth as the company has announced a string of new orders. Most recently, the company has signed three new contracts for five devices to be used by clients in New York, Nevada, and Oklahoma. The new orders represent the value and diversity Knightscope products for an array of uses and across a broad spectrum. The Knightscope devices will be used on a college campus in New York, a park in Oklahoma and a city in Nevada. “The goal of…

Continue Reading

ThursdayOct 05, 2023 12:26 pm

QualityStocksNewsBreaks – Electronic Servitor Publication Network Inc.’s (XESP) Digital Engagement Engine(TM) Creating Digital Experiences That Drive Growth

Electronic Servitor Publication Network (OTC: XESP) is a digital engagement company offering a Managed Service that provides unique digital activation and engagement solutions to businesses that seek to optimize growth. The company is making a difference in the global customer engagement solutions market. “The company’s Managed Service is powered by a proven, proprietary technology – the Digital Engagement Engine(TM) – which provides intelligent interaction management, dynamic content provisioning, and a logic-driven workflow, which creates digital experiences that accelerate an audience from awareness to action and drive growth. Electronic Servitor Publication Network’s Digital Engagement Engine(TM) was designed to drive growth for…

Continue Reading

ThursdayOct 05, 2023 12:14 pm

QualityStocksNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces ACS Donation, ‘Spin for a Cure’ Event

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, today announced a planned donation of $10,000 to the American Cancer Society (“ACS”) in honor of Breast Cancer Awareness Month. According to the update, DoubleDown Casino, which is played daily by millions of fans worldwide on both desktop and mobile devices, will invite players to engage with and show support for the charitable donation by taking part in a play-to-enter giveaway on Oct. 11, 2023. The “Spin for a Cure” event offers players the chance to express their enthusiasm for helping the American…

Continue Reading

ThursdayOct 05, 2023 12:05 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Reports Top-Line Results for Phase 2a Lomecel-B Clinical Trial

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has released top-line results for its phase 2a trial of its investigational product Lomecel-B(TM). The study evaluated Lomecel-B for the treatment of mild Alzheimer’s disease. According to the report, the primary endpoint of safety was met across all study groups; in addition, the secondary endpoint of change from baseline to week 39 in Composite Alzheimer’s Disease Score (“CADS”) also demonstrated positive results. The report also noted that other doses demonstrated numerical…

Continue Reading

ThursdayOct 05, 2023 11:29 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces $45.1M NINDS Grant to Support Expanded Access Protocol for CNM-Au8(R) in ALS

Clene (NASDAQ: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, was awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (“NINDS”), a division of the National Institutes of Health (“NIH”). The grant is to support an Expanded Access Protocol (“EAP”) for the company’s investigational drug, CNM-Au8(R), in amyotrophic lateral sclerosis (“ALS”). Also referred to as Compassionate Use, an EAP is an FDA-regulated pathway that allows people with a serious and life-threatening disease to access an investigational drug that is not yet approved by the U.S.…

Continue Reading

WednesdayOct 04, 2023 3:13 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASR, K1 Hemisphere for New Contracts in Southern California

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced two new contracts from a Los Angeles area shopping center and a medical clinic. The announcement reads, “The Knightscope K5 Autonomous Security Robot (‘ASR’) will be patrolling the interior of a large, cultural mall in the Los Angeles area. Shopping centers are places where people go to shop, dine, relax, browse or meet in a fun and safe atmosphere. Providing that safe environment reduces vacancies, mitigates risk, elevates property values and increases foot traffic. Knightscope ASRs have already successfully deterred substance abuse,…

Continue Reading

WednesdayOct 04, 2023 2:26 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Issues Response to Short Seller Report

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is responding to the Oct. 3, 2023, short seller report issued by Capybara Research, a short-selling research firm. According to the statement, FingerMotion management reviewed the report and believe that the report contains errors, unsupported speculations and inaccurate interpretations of events; management and the company’s board of directors are planning further review and examination of allegations and misinformation contained in the report. The company “will take whatever necessary and appropriate actions may be required to protect the interest of its shareholders,” the announcement stated. “The company is already in the process…

Continue Reading

WednesdayOct 04, 2023 1:58 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Unveil Encouraging Data on REQORSA(R) for Lung Cancer Treatment at 2023 AACR-NIH-EORTC Conference

Genprex (NASDAQ: GNPX) is at the forefront of pioneering cancer treatments, and it’s making waves with remarkable advancements in lung cancer therapy. The company will be sharing compelling clinical and preclinical data at the prestigious 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place October 11-15 at the Hynes Convention Center in Boston. The Acclaim-1 Phase 1 study results have demonstrated the safety and efficacy of REQORSA(R) in combination with Tagrisso(R), bringing hope to patients with late-stage NSCLC. Moreover, preclinical studies have highlighted REQORSA(R)'s potential in combination with a checkpoint inhibitor to combat chemotherapy-resistant small cell lung…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered